Safeguard Scientifics, Inc.
SFES
$0.89
$0.03253.79%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.02% | -3.20% | -2.32% | -17.44% | -22.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.02% | -3.20% | -2.32% | -17.44% | -22.40% |
| Operating Income | -19.02% | 3.20% | 2.32% | 17.44% | 22.40% |
| Income Before Tax | 31.09% | 42.93% | -514.14% | -513.41% | -152.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.09% | 42.93% | -514.14% | -513.41% | -152.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.09% | 42.93% | -514.14% | -513.41% | -152.82% |
| EBIT | -19.02% | 3.20% | 2.32% | 17.44% | 22.40% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 30.41% | 41.02% | -12,620.00% | -1,219.69% | -172.86% |
| Normalized Basic EPS | 6.34% | -214.78% | -202.91% | -248.73% | -143.07% |
| EPS Diluted | 28.72% | 40.64% | -7,431.93% | -1,018.57% | -173.65% |
| Normalized Diluted EPS | 6.34% | -214.78% | -202.91% | -248.73% | -143.10% |
| Average Basic Shares Outstanding | -0.73% | -2.10% | -8.36% | -13.57% | -17.62% |
| Average Diluted Shares Outstanding | -0.73% | -2.10% | -8.36% | -13.57% | -17.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |